FC
XBI icon

Fore Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Fore Capital’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-200,000
Closed -$18.1M – 59
2018
Q1 		$18.1M Buy
200,000
+169,000
+545% +$15.4M 5.07% 5
2017
Q4 		$2.63M Buy
+31,000
New +$2.6M 1.02% 28

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Fore Capital's XBI Position: Q4 2024 in Review

Fore Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 25,000 shares — an estimated $2.47M sold.

Fore Capital first reported a position in XBI in Q2 2021 and held it in 2 quarters. The position peaked at $2.47M in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

  • Fore Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
  • Fore Capital sold 25,000 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $2.47M.
  • Fore Capital first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 2 quarters.
  • Fore Capital's State Street SPDR S&P Biotech ETF position peaked at $2.47M in Q3 2024.
  • 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Fore Capital's 13F filing for Q4 2024, filed 10 Feb 2025.